PLEURAMED
DEAD

Serial Number

98293621

Owner

TDL Innovations LLC

Attorney

Christopher D. Olszyk, Jr.

Filing Date

Nov 30, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PLEURAMED Trademark

Serial Number: 98293621

PLEURAMED is a trademark filed by TDL Innovations LLC on November 30, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

TDL Innovations LLC (6 trademarks)

Princeton, NJ 08540

Entity Type: 16

Trademark Details

Filing Date

November 30, 2023

Registration Date

Not Registered

Published for Opposition

August 6, 2024

Goods & Services

Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Scientific research for medical purposes in the field of cancerous diseases; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical drug development services; Clinical research in the fields of cancer treatments, prevention and surgical procedures

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 4, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 4, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 2, 2025 EXRA
SOU EXTENSION 2 GRANTED
Oct 1, 2025 EX2G
SOU EXTENSION 2 FILED
Oct 1, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 1, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 29, 2025 EXRA
SOU EXTENSION 1 GRANTED
Mar 29, 2025 EX1G
SOU EXTENSION 1 FILED
Mar 28, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 28, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 1, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 6, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 6, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 17, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 29, 2024 CNSA
ASSIGNED TO EXAMINER
Jun 28, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2024 NWOS
NEW APPLICATION ENTERED
Dec 1, 2023 NWAP